Kraig Biocraft Current Valuation vs. Beta
| KBLB Stock | USD 0.13 0.02 18.18% |
For Kraig Biocraft profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Kraig Biocraft to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Kraig Biocraft Labs utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Kraig Biocraft's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Kraig Biocraft Labs over time as well as its relative position and ranking within its peers.
Kraig |
Kraig Biocraft Labs Beta vs. Current Valuation Fundamental Analysis
Comparative valuation techniques use various fundamental indicators to help in determining Kraig Biocraft's current stock value. Our valuation model uses many indicators to compare Kraig Biocraft value to that of its competitors to determine the firm's financial worth. Kraig Biocraft Labs is rated fifth overall in current valuation category among its peers. It also is rated fifth overall in beta category among its peers . The ratio of Current Valuation to Beta for Kraig Biocraft Labs is about 101,680,024 . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Kraig Biocraft's earnings, one of the primary drivers of an investment's value.Kraig Current Valuation vs. Competition
Kraig Biocraft Labs is rated fifth overall in current valuation category among its peers. After adjusting for long-term liabilities, total market size of Materials industry is now estimated at about 5.58 Billion. Kraig Biocraft maintains roughly 34.14 Million in current valuation contributing less than 1% to all equities under Materials industry.
Kraig Beta vs. Current Valuation
Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Kraig Biocraft |
| = | 34.14 M |
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
Beta is one of the most important measures of equity market volatility. Beta can be thought of as asset elasticity or sensitivity to market. In other words, it is a number that shows the relationship of an equity instrument to the financial market in which this instrument is traded. For example, if Beta of equity is 2, it is expected to significantly outperform market when the market is going up and significantly underperform when the market is going down. Similarly, Beta of 1 indicates that an asset and market will generate similar returns over time.
Kraig Biocraft |
| = | 0.34 |
In a nutshell, Beta is a measure of individual stock risk relative to the overall volatility of the stock market. and is calculated based on very sound finance theory - Capital Assets Pricing Model (CAPM).However, since Beta is calculated based on historical price movements it may not predict how a firm's stock is going to perform in the future.
Kraig Beta Comparison
Kraig Biocraft is currently under evaluation in beta category among its peers.
Beta Analysis
As returns on the market increase, Kraig Biocraft's returns are expected to increase less than the market. However, during the bear market, the loss of holding Kraig Biocraft is expected to be smaller as well.
Kraig Biocraft Profitability Projections
The most important aspect of a successful company is its ability to generate a profit. For investors in Kraig Biocraft, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Kraig Biocraft will eventually generate negative long term returns. The profitability progress is the general direction of Kraig Biocraft's change in net profit over the period of time. It can combine multiple indicators of Kraig Biocraft, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
Kraig Biocraft Laboratories, Inc. engages in developing protein-based fibers using recombinant DNA technology for commercial applications in the technical textile and specialty fiber industries in the United States. The company was incorporated in 2006 and is headquartered in Ann Arbor, Michigan. Kraig Biocraft operates under Specialty Chemicals classification in the United States and is traded on OTC Exchange. It employs 38 people.
Kraig Profitability Driver Comparison
Profitability drivers are factors that can directly affect your investment outlook on Kraig Biocraft. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Kraig Biocraft position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Kraig Biocraft's important profitability drivers and their relationship over time.
Use Kraig Biocraft in pair-trading
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Kraig Biocraft position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Kraig Biocraft will appreciate offsetting losses from the drop in the long position's value.Kraig Biocraft Pair Trading
Kraig Biocraft Labs Pair Trading Analysis
The ability to find closely correlated positions to Kraig Biocraft could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Kraig Biocraft when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Kraig Biocraft - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Kraig Biocraft Labs to buy it.
The correlation of Kraig Biocraft is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Kraig Biocraft moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Kraig Biocraft Labs moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Kraig Biocraft can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Use Investing Themes to Complement your Kraig Biocraft position
In addition to having Kraig Biocraft in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Macroaxis Picks Thematic Idea Now
Macroaxis Picks
Daily selected watch list of stocks of large companies handpicked by Macroaxis Team based on their diversification potential. The Macroaxis Picks theme has 50 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Macroaxis Picks Theme or any other thematic opportunities.
| View All Next | Launch |
Other Information on Investing in Kraig OTC Stock
To fully project Kraig Biocraft's future profitability, investors should examine all historical financial statements. These statements provide investors with a comprehensive snapshot of the financial position of Kraig Biocraft Labs at a specified time, usually calculated after every quarter, six months, or one year. Three primary documents fall into the category of financial statements. These documents include Kraig Biocraft's income statement, its balance sheet, and the statement of cash flows.